[1]
I. A. Pereira, . F. R. A. Ferry, R. M. P. Alvarenga, and C. A. M. Sá, “Toxoplasma encephalitis after initiation of highly active anti-retroviral therapy (Haart)”, DST, vol. 20, no. 1, pp. 52–58, Jan. 2008.